Status:
COMPLETED
Telemedicin Counselling for Medical Abortion
Lead Sponsor:
Karolinska Institutet
Conditions:
Medical Abortion Counselling
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The guidance on Safe abortion technology by the World Health Organization (WHO 2012) suggests the evaluation of internet provision and telemedicine, as further alternative service delivery channels of...
Eligibility Criteria
Inclusion
- requesting termination of pregnancy by means of mifepristone followed by home administration of misoprostol at \< /=63 days of gestation, no contraindication to medical abortion and self administration of misoprostol at home, and who have given their informed consent
Exclusion
- women who do not want home administration of misoprostol, women who are unable to communicate in Swedish, or English, and women with symptoms and signs of ectopic pregnancy.
Key Trial Info
Start Date :
April 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
1598 Patients enrolled
Trial Details
Trial ID
NCT03461653
Start Date
April 4 2018
End Date
September 30 2024
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 17176